Surgery News and Research

RSS

SIS to offer AORN SYNTEGRITY SPF within perioperative management solutions suite

Helping to streamline electronic documentation processes for perioperative care, CSC and the Association of periOperative Registered Nurses (AORN) announced today that Surgical Information Systems (SIS), the perioperative IT specialist, will offer the AORN SYNTEGRITYTM Standardized Perioperative Framework (SPF) within its nationally recognized suite of perioperative management solutions.

3 Mar 2010

PINC trial to test anti-malarial drug in women with DCIS

Can a drug that has been used to treat malaria for years possibly be used to treat breast cancer before it becomes invasive? That's what researchers at George Mason University's Center for Applied Proteomics and Molecular Medicine (CAPMM) and Inova Breast Care Institute (IBCI) are trying to prove.

3 Mar 2010

Robotic surgery does not compromise clinical outcomes for prostate cancer surgery

Robotic surgical technology with its three-dimensional, high-definition view gives surgeons the sensation of touch, even as they operate from a remote console. A new study describes the phenomenon, called intersensory integration, and reports that surgical outcomes for prostate cancer surgery using minimally invasive robotic technology compare favorably with traditional invasive surgery.

3 Mar 2010

Starting radiotherapy as soon as possible could minimise breast cancer recurrence

The longer women wait for radiotherapy after breast cancer surgery, the more chance there is of local recurrence, concludes a study published on bmj.com today.

3 Mar 2010

Enlarged prostate: Dutasteride-tamsulosin combination therapy more effective

Like any successful team effort, the best qualities of two drugs commonly prescribed for enlarged prostate yielded better results than either of the medicines alone, according to a new study from UT Southwestern Medical Center.

3 Mar 2010

ICU survivors face high risk of death in following years, says study

An analysis of Medicare data indicates that elderly patients who are hospitalized in an intensive care unit (ICU) and survive to be discharged from the hospital have a high rate of death in the following three years, and that, in particular, patients who receive mechanical ventilation have a substantially increased rate of death compared with both hospital and general population controls in the first several months after hospital discharge, according to a study in the March 3 issue of JAMA.

3 Mar 2010

Exactech receives FDA marketing clearance for Equinoxe Platform Fracture Stem

Exactech, Inc., a developer and producer of bone and joint restoration products for hip, knee, shoulder, spine and biologic materials, announced today that the company has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market the company’s Equinoxe® Platform Fracture Stem, the latest addition to the company’s shoulder arthroplasty line.

3 Mar 2010

Study shows cryoablation technique offers a potential treatment for breast cancer

Freezing a cancer kills it in its place, and also appears to generate an immune response that helps stop the cancer's spread, leading to improved survival rates over surgery, according to a new study in mice from researchers at the University of Michigan Comprehensive Cancer Center.

3 Mar 2010

Corneal transplant surgery: DSAEK leads to greater cell loss overall than PKP

One year post-surgery, patients who underwent Descemet's stripping automated endothelial keratoplasty (DSAEK) experienced greater cell loss overall compared to those who underwent penetrating keratoplasty (PKP), according to a new analysis of data collected from the Cornea Donor Study (CDS) Investigator Group's 2008 Specular Microscopy Ancillary Study (SMAS). However, the study, published in the March issue of Ophthalmology, showed that cell loss in DSAEK patients plateaued more quickly than in those who underwent PKP.

2 Mar 2010

St. Jude Medical's Trifecta valve receives CE Mark approval

St. Jude Medical, Inc. today announced that it has received CE Mark approval for the Trifecta™ valve, marking the Company’s launch into the market for pericardial aortic stented tissue valves.

2 Mar 2010

Intercell AG's revenues for full year 2009 increase 10.6%

Today, the biotech-vaccine company Intercell AG announced its financial results for Q4 and the preliminary results for the full financial year 2009, and presented an update on the Company's development programs.

2 Mar 2010

Colonoscopy screening recommended for people with family history of colon cancer

A family history of colon cancer, also known as colorectal cancer or CRC, puts people at higher than average risk for developing the disease.

2 Mar 2010

Balloon Sinuplasty minimally invasive surgery safe for treating chronic sinusitis in children

A recently published study in the American Journal of Rhinology and Allergy demonstrates Balloon Sinuplasty™ technology to be safe when used by physicians in pediatric patients. Known as the INTACT study, this is a prospective, non-randomized, multicenter study and was sponsored by Acclarent, Inc.

2 Mar 2010

Canyon Pharmaceuticals announces the availability of Iprivask inhibitor for prevention of DVT

Canyon PharmaceuticalsTM (www.canyonpharma.com) today announced the availability of Iprivask (desirudin for injection), the first direct thrombin inhibitor (DTI) approved in the United States by the Food and Drug Administration for the prevention of deep vein thrombosis (DVT), which may lead to pulmonary embolism in patients undergoing elective hip replacement surgery.

2 Mar 2010

Gene research offers new hope for targeted breast cancer treatment

CANCER RESEARCH UK scientists have developed a system to identify faulty or missing genes that could prevent specific chemotherapy regimes from working. This opens the doors for targeted breast cancer treatment, according to research published in the Lancet Oncology* today (Monday).

2 Mar 2010

Celsion to commence Phase II Study of ThermoDox and RFA for CRLM

Celsion Corporation today announced that it will initiate a Randomized Phase II Study of Lyso-Thermosensitive Liposomal Doxorubicin (ThermoDox®) and Radiofrequency Ablation (RFA) for Colorectal Liver Metastases (CRLM). Dr. Steven K. Libutti, Professor and Vice Chairman, Department of Surgery and Director of the Montefiore-Einstein Center for Cancer Care and Albert Einstein College of Medicine in New York City, will serve as Principal Investigator for the study.

2 Mar 2010

Study shows high rate of shoulder dislocation in young males and elderly women

An article published in the March 2010 issue of The Journal of Bone and Joint Surgery reveals that the majority of all shoulder dislocations occur during sports activities and young males are at a higher risk. The study also shows a high rate of shoulder dislocation in elderly women.

2 Mar 2010

MiMedx Group's HydroFix Spine Shield device receives CE Mark

MiMedx Group, Inc. announced today that the Company received the CE Mark for its HydroFix™ Spine Shield device and was certified for design, development, and production of post-surgical adhesion inhibiting barriers.

1 Mar 2010

ATS Medical: First human robot assisted endoscopic aortic valve replacement in the Midwest

ATS Medical, Inc., manufacturer and marketer of state-of-the-art cardiac surgery products and services today announced the first human robot assisted endoscopic aortic valve replacement in the Midwest using the daVinci® Surgical System from Intuitive Surgical to implant the ATS 3f ® Aortic Bioprosthesis. The procedure was recently performed by Husam H. Balkhy, M.D., at the Wisconsin Heart Hospital in Milwaukee, Wisconsin.

1 Mar 2010

Bayer HealthCare Pharmaceuticals' RECOTHROM solution receives Health Canada approval

Bayer HealthCare Pharmaceuticals announced today that RECOTHROM(R) (Thrombin alfa (Recombinant)), the first recombinant, plasma-free thrombin approved by Health Canada, is now available for use as a topical hemostatic solution. According to a recent clinical study, RECOTHROM(R) was found to successfully stop 80 per cent of surgical bleeding within three minutes and 95 per cent of bleeding within 10 minutes.

1 Mar 2010

Surgery News and Research

SIS to offer AORN SYNTEGRITY SPF within perioperative management solutions suite

PINC trial to test anti-malarial drug in women with DCIS

Robotic surgery does not compromise clinical outcomes for prostate cancer surgery

Starting radiotherapy as soon as possible could minimise breast cancer recurrence

Enlarged prostate: Dutasteride-tamsulosin combination therapy more effective

ICU survivors face high risk of death in following years, says study

Exactech receives FDA marketing clearance for Equinoxe Platform Fracture Stem

Study shows cryoablation technique offers a potential treatment for breast cancer

Corneal transplant surgery: DSAEK leads to greater cell loss overall than PKP

St. Jude Medical's Trifecta valve receives CE Mark approval

Intercell AG's revenues for full year 2009 increase 10.6%

Colonoscopy screening recommended for people with family history of colon cancer

Balloon Sinuplasty minimally invasive surgery safe for treating chronic sinusitis in children

Canyon Pharmaceuticals announces the availability of Iprivask inhibitor for prevention of DVT

Gene research offers new hope for targeted breast cancer treatment

Celsion to commence Phase II Study of ThermoDox and RFA for CRLM

Study shows high rate of shoulder dislocation in young males and elderly women

MiMedx Group's HydroFix Spine Shield device receives CE Mark

ATS Medical: First human robot assisted endoscopic aortic valve replacement in the Midwest

Bayer HealthCare Pharmaceuticals' RECOTHROM solution receives Health Canada approval

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News